Hassan Javanbakht, PhD

Over 15 years of experience in both virology and viral immunology that expands across all stages of preclinical drug discovery and development. Prior to SQZ, he was a senior director at Gilead Sciences where he led a team of senior scientists developing novel therapies to treat chronic Hepatitis B infection. He has authored more than 45 peer-reviewed scientific publications in high impact journals so far and holds more than 10 issued patents and applications.